Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's disease could soon be here
Patient participation in clinical trials enhances understanding and treatment of debilitating diseases, exemplified by Andrew Cassy's involvement after his Parkinson's diagnosis.
How Clinical Trials Software Companies Are Revolutionizing Medical Research
Clinical trials software accelerates medical research by automating processes like data management, patient recruitment, and compliance monitoring.
Could the Key to Understanding Long COVID Be Found in the Gut?
A new clinical trial at Massachusetts General Hospital aims to understand and treat long COVID in young patients aged 7 to 21.
Research Grid raises $6.4M to automate clincal trial admin | TechCrunch
Amber Hill created Research Grid to automate administrative tasks in clinical trials, aiming to enhance efficiency and reduce delays.
People didn't believe Africa could be a source of innovation': how the continent holds the key to future drug research
Africa's genetic diversity is essential for global health advancements, yet it is underutilized in clinical trials.
Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's disease could soon be here
Patient participation in clinical trials enhances understanding and treatment of debilitating diseases, exemplified by Andrew Cassy's involvement after his Parkinson's diagnosis.
How Clinical Trials Software Companies Are Revolutionizing Medical Research
Clinical trials software accelerates medical research by automating processes like data management, patient recruitment, and compliance monitoring.
Could the Key to Understanding Long COVID Be Found in the Gut?
A new clinical trial at Massachusetts General Hospital aims to understand and treat long COVID in young patients aged 7 to 21.
Research Grid raises $6.4M to automate clincal trial admin | TechCrunch
Amber Hill created Research Grid to automate administrative tasks in clinical trials, aiming to enhance efficiency and reduce delays.
People didn't believe Africa could be a source of innovation': how the continent holds the key to future drug research
Africa's genetic diversity is essential for global health advancements, yet it is underutilized in clinical trials.
New Psychiatric Technique Asks Schizophrenics to Engage in Dialogue With the Voices in Their Heads
Avatar therapy uses digital avatars to help people confront and manage auditory hallucinations effectively.
People with depression could administer brain stimulation at home, trial shows
Self-administered electrical brain stimulation may effectively alleviate major depression symptoms at home, particularly for those unresponsive to traditional therapies.
Grasping for hope: The heartbreaking journey through Alzheimer's drug trials
John's emotional journey with Cheryl highlights the complexity of caring for a loved one with Alzheimer's and the search for effective treatments.
Studying the Mental Health Impact of Weight Loss Drugs - News Center
Semaglutide is safe for those without significant mental health disorders, based on a recent clinical trial.
Study reveals the limited research on ADHD treatments for adults
ADHD is often misperceived as a childhood disorder, leading to limited treatment options for adults suffering from it.
A new $25M fund aims to give UK mental health startups a shot in the arm | TechCrunch
KHP Ventures is launching a £20 million fund to support mental health startups addressing depression, anxiety, and psychosis, in collaboration with major healthcare providers.
New Psychiatric Technique Asks Schizophrenics to Engage in Dialogue With the Voices in Their Heads
Avatar therapy uses digital avatars to help people confront and manage auditory hallucinations effectively.
People with depression could administer brain stimulation at home, trial shows
Self-administered electrical brain stimulation may effectively alleviate major depression symptoms at home, particularly for those unresponsive to traditional therapies.
Grasping for hope: The heartbreaking journey through Alzheimer's drug trials
John's emotional journey with Cheryl highlights the complexity of caring for a loved one with Alzheimer's and the search for effective treatments.
Studying the Mental Health Impact of Weight Loss Drugs - News Center
Semaglutide is safe for those without significant mental health disorders, based on a recent clinical trial.
Study reveals the limited research on ADHD treatments for adults
ADHD is often misperceived as a childhood disorder, leading to limited treatment options for adults suffering from it.
A new $25M fund aims to give UK mental health startups a shot in the arm | TechCrunch
KHP Ventures is launching a £20 million fund to support mental health startups addressing depression, anxiety, and psychosis, in collaboration with major healthcare providers.
Wireless brain-computer interface technology advanced during the pandemic, allowing research to continue and participants to engage remotely.
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Science Corporation has developed a groundbreaking retinal implant, Prima, that restores eyesight in legally blind patients, marking a significant advance in biomedical technology.
Neuralink brain trials head for Canada
Neuralink is recruiting participants for its neurotech trial, aiming to enable computer control through thought.
The study targets individuals with severe motor impairments due to spinal injuries or ALS.
Neuralink gets approval to start human trials in Canada
Neuralink will conduct its first human clinical trials in Canada, focusing on brain-computer interface technology.
Elon Musk's Neuralink to launch new brain-implant trial involving robotic arm
Neuralink is advancing trials for its brain-computer interface to assist individuals with quadriplegia through direct thought control of devices.
The future of neuroscience could be wireless
Wireless brain-computer interface technology advanced during the pandemic, allowing research to continue and participants to engage remotely.
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Science Corporation has developed a groundbreaking retinal implant, Prima, that restores eyesight in legally blind patients, marking a significant advance in biomedical technology.
Neuralink brain trials head for Canada
Neuralink is recruiting participants for its neurotech trial, aiming to enable computer control through thought.
The study targets individuals with severe motor impairments due to spinal injuries or ALS.
Neuralink gets approval to start human trials in Canada
Neuralink will conduct its first human clinical trials in Canada, focusing on brain-computer interface technology.
Elon Musk's Neuralink to launch new brain-implant trial involving robotic arm
Neuralink is advancing trials for its brain-computer interface to assist individuals with quadriplegia through direct thought control of devices.
Drug, now in testing, has promise for epileptic seizures
BHV-7000 offers hope for treating drug-resistant seizures by activating potassium receptors, a new avenue for epilepsy treatment with minimal side effects.
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes - News Center
Endovascular thrombectomy did not significantly improve outcomes after 90 days for patients with large core strokes compared to standard care.
Drug, now in testing, has promise for epileptic seizures
BHV-7000 offers hope for treating drug-resistant seizures by activating potassium receptors, a new avenue for epilepsy treatment with minimal side effects.
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes - News Center
Endovascular thrombectomy did not significantly improve outcomes after 90 days for patients with large core strokes compared to standard care.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Which disease-modifying Alzheimer's drugs are the most promising?
The UK health watchdog has rejected two new Alzheimer's drugs due to concerns over their effectiveness and potential side effects.
Francisco Lopera obituary: neurologist who traced genetic origin of early-onset Alzheimer's
Francisco Lopera's family-centered approach transformed Alzheimer's research, enhancing understanding of the disease's genetics and fostering trust in clinical settings.
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results
Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The regulatory approval path for simufilam is fraught with controversy and allegations of research misconduct.
Which disease-modifying Alzheimer's drugs are the most promising?
The UK health watchdog has rejected two new Alzheimer's drugs due to concerns over their effectiveness and potential side effects.
Francisco Lopera obituary: neurologist who traced genetic origin of early-onset Alzheimer's
Francisco Lopera's family-centered approach transformed Alzheimer's research, enhancing understanding of the disease's genetics and fostering trust in clinical settings.
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results
Cassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Elon Musk's Neuralink gets first-ever approval outside of U.S.
Neuralink receives approval for its first clinical trial in Canada, aiming to assess its brain implant's safety and functionality for treating paralysis and mental health disorders.
Les Turner Symposium on ALS Unites Community Around Research and Patient Care - News Center
The 14th annual Les Turner Symposium on ALS highlights collaborative research efforts aimed at improving understanding and treatment of ALS.
Elon Musk's Neuralink gets first-ever approval outside of U.S.
Neuralink receives approval for its first clinical trial in Canada, aiming to assess its brain implant's safety and functionality for treating paralysis and mental health disorders.
Les Turner Symposium on ALS Unites Community Around Research and Patient Care - News Center
The 14th annual Les Turner Symposium on ALS highlights collaborative research efforts aimed at improving understanding and treatment of ALS.
Trialbee Sees Significant Growth While Focusing on Innovation in Patient Recruitment
Trialbee reported a 60% increase in net revenue in 2023, reflecting strong demand for its patient recruitment services despite a reported loss.
Delft-based OASYS NOW wins Slush 100 competition - Silicon Canals
OASYS NOW is revolutionizing patient recruitment for clinical trials with an AI-powered platform, potentially saving lives and enhancing drug development efficiency.
Trialbee Sees Significant Growth While Focusing on Innovation in Patient Recruitment
Trialbee reported a 60% increase in net revenue in 2023, reflecting strong demand for its patient recruitment services despite a reported loss.
Delft-based OASYS NOW wins Slush 100 competition - Silicon Canals
OASYS NOW is revolutionizing patient recruitment for clinical trials with an AI-powered platform, potentially saving lives and enhancing drug development efficiency.
Immunotherapy Shows Potential to Treat Deadly Thyroid Cancer - News Center
Combination immunotherapy shows promise in treating anaplastic thyroid carcinoma, a rare and aggressive form of thyroid cancer, with a response rate of 30%.
World-first lung cancer vaccine trials launched across seven countries
The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.
Immunotherapy Shows Potential to Treat Deadly Thyroid Cancer - News Center
Combination immunotherapy shows promise in treating anaplastic thyroid carcinoma, a rare and aggressive form of thyroid cancer, with a response rate of 30%.
World-first lung cancer vaccine trials launched across seven countries
The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.
Why do obesity drugs seem to treat so many other ailments?
GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.
New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent
Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor | Kenan Malik
The UK is exploring pilot schemes to improve obesity care with pharmaceutical companies, focusing on economic outcomes rather than individual health benefits.
Five Top Obesity Stocks to Buy and Hold Long Term
Viking Therapeutics' VK2735 obesity treatment stock presents a promising investment opportunity ahead of its Phase 3 trials due to recent positive data.
Why do obesity drugs seem to treat so many other ailments?
GLP-1 drugs may reduce cravings for alcohol and other addictions while also addressing obesity and other health conditions.
New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent
Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor | Kenan Malik
The UK is exploring pilot schemes to improve obesity care with pharmaceutical companies, focusing on economic outcomes rather than individual health benefits.
Five Top Obesity Stocks to Buy and Hold Long Term
Viking Therapeutics' VK2735 obesity treatment stock presents a promising investment opportunity ahead of its Phase 3 trials due to recent positive data.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
More good news about the twice-yearly PrEP injection - Queerty
Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
This preventive drug could be a 'game changer' in ending the HIV epidemic
Lenacapavir shows potential to significantly reduce new HIV infections, fostering optimism towards the goal of ending the epidemic by 2030.
More good news about the twice-yearly PrEP injection - Queerty
Lenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
Stem Cell Treatment Worked on One Patient's Type 1 Diabetes
Stem cell therapy shows promising results in reversing type 1 diabetes, leading to sustained insulin independence and improved glycemic control.
Study Suggests Fasting's Benefits Might Start When It Stops
Fasting has potential health benefits, particularly related to fat metabolism and intestinal repair, yet may also carry risks like increasing precancerous cells.
Stem Cell Treatment Worked on One Patient's Type 1 Diabetes
Stem cell therapy shows promising results in reversing type 1 diabetes, leading to sustained insulin independence and improved glycemic control.
Study Suggests Fasting's Benefits Might Start When It Stops
Fasting has potential health benefits, particularly related to fat metabolism and intestinal repair, yet may also carry risks like increasing precancerous cells.
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq
BioAge Labs is entering the public market with its obesity drug Azelaprag in clinical trials, aiming for significant growth and competition in the weight loss sector.
Data integrity concerns flagged in 130 women's health papers - all by one co-author
Concerns about data integrity have been raised in 130 studies by a biomedical researcher, influencing clinical practice rooted in questionable data.
Treatment Strategies for CNS Complications in People with HIV
Identify modifiable targets and mechanisms to improve CNS-related outcomes in individuals with HIV, enhancing their quality of life and functional capacity.
Pfizer drug helped cancer patients regain weight, study shows
Pfizer's ponsegromab shows potential in helping cancer patients regain weight lost due to cachexia.
Roche stock drops 5% after report its Wegovy challenger is causing patients to vomit
Roche's obesity pill faces challenges with side effects that may impact its competitive edge in the weight-loss pharmaceutical market.
Can you starve cancer cells with a low-carb diet? A clinical trial seeks to find out
A fasting-mimicking diet might ease chemotherapy side effects and improve treatment success.
More bad news for psychedelic drug company: FDA expands probe after rejection
The FDA's rejection of Lykos' MDMA therapy has prompted a deeper investigation into clinical trial misconduct and serious allegations.
Opinion | How Psychedelic Research Got High on Its Own Supply
Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity.
Day Two: Placebo Workshop: Translational Research Domains and Key Questions
The NIMH Placebo Workshop is focused on exploring the role and implications of placebo in clinical research.
More bad news for psychedelic drug company: FDA expands probe after rejection
The FDA's rejection of Lykos' MDMA therapy has prompted a deeper investigation into clinical trial misconduct and serious allegations.
Opinion | How Psychedelic Research Got High on Its Own Supply
Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity.
Day Two: Placebo Workshop: Translational Research Domains and Key Questions
The NIMH Placebo Workshop is focused on exploring the role and implications of placebo in clinical research.